- 5 Resultados
precio mínimo: € 65,99, precio máximo: € 171,03, precio promedio: € 131,30
1
Pedir
por AbeBooks.de
€ 85,97
Envío: € 0,001
PedirEnlace patrocinado
Giordano, Antonio / Normanno, Nicola:

Breast Cancer in the Post-Genomic Era - libro nuevo

ISBN: 1607614669

[EAN: 9781607614661], Neubuch, Publisher/Verlag: Springer, Berlin | Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakth… Más…

  - NEW BOOK Gastos de envío:Versandkostenfrei (EUR 0.00) English-Book-Service - A Fine Choice, Waldshut-Tiengen, Germany [1048135] [Rating: 4 (von 5)]
2
Breast Cancer in the Post-Genomic Era - Nicola Normanno#Antonio Giordano
Pedir
por Orellfuessli.ch
CHF 183,00
(aprox. € 163,61)
Envío: € 16,091
PedirEnlace patrocinado

Nicola Normanno#Antonio Giordano:

Breast Cancer in the Post-Genomic Era - libro nuevo

2013, ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Más…

No. 17938214. Gastos de envío:Zzgl. Versandkosten. (EUR 16.09)
3
Breast Cancer in the Post-Genomic Era - Nicola Normanno#Antonio Giordano
Pedir
por Thalia.de
€ 65,99
Envío: € 0,001
PedirEnlace patrocinado
Nicola Normanno#Antonio Giordano:
Breast Cancer in the Post-Genomic Era - libro nuevo

ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Más…

  - No. 17938214. Gastos de envío:, Lieferbar in 2 - 3 Wochen, DE. (EUR 0.00)
4
Breast Cancer in the Post-Genomic Era - Nicola Normanno#Antonio Giordano
Pedir
por Orellfuessli.ch
CHF 183,00
(aprox. € 169,92)
Envío: € 16,711
PedirEnlace patrocinado
Nicola Normanno#Antonio Giordano:
Breast Cancer in the Post-Genomic Era - Pasta blanda

2013, ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Más…

Nr. 17938214. Gastos de envío:, wird besorgt, Lieferzeit unbekannt, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.71)
5
Breast Cancer in the Post-Genomic Era
Pedir
por Orellfuessli.ch
CHF 183,00
(aprox. € 171,03)
PedirEnlace patrocinado
Breast Cancer in the Post-Genomic Era - Pasta blanda

2013, ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Más…

Nr. 17938214. Gastos de envío:Does not ship to your country., más gastos de envío

1Dado que algunas plataformas no nos comunican las condiciones de envío y éstas pueden depender del país de entrega, del precio de compra, del peso y tamaño del artículo, de una posible membresía a la plataforma, de una entrega directa por parte de la plataforma o a través de un tercero (Marketplace), etc., es posible que los gastos de envío indicados por eurolibro/terralibro no concuerden con los de la plataforma ofertante.

Datos bibliográficos del mejor libro coincidente

Detalles del libro
Breast Cancer in the Post-Genomic Era

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma. The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist.

Detalles del libro - Breast Cancer in the Post-Genomic Era


EAN (ISBN-13): 9781607614661
ISBN (ISBN-10): 1607614669
Tapa dura
Tapa blanda
Año de publicación: 201307
Editorial: Springer
230 Páginas
Idioma: Englisch

Libro en la base de datos desde 2009-10-31T12:21:07-06:00 (Mexico City)
Página de detalles modificada por última vez el 2021-06-05T14:18:20-05:00 (Mexico City)
ISBN/EAN: 1607614669

ISBN - escritura alterna:
1-60761-466-9, 978-1-60761-466-1
Mode alterno de escritura y términos de búsqueda relacionados:
Autor del libro: giordano
Título del libro: cancer the breast, post


Datos del la editorial

Autor: Antonio Giordano; Nicola Normanno
Título: Current Clinical Oncology; Breast Cancer in the Post-Genomic Era
Editorial: Humana Press
230 Páginas
Año de publicación: 2013-09-01
Impreso en
Idioma: Inglés
79,29 € (DE)
81,51 € (AT)
115,00 CHF (CH)
Available

BC; PB; Hardcover, Softcover / Medizin/Klinische Fächer; Klinische und Innere Medizin; Verstehen; Mammory Glands; Breast Cancer; Gene Expression; TGF-B Signaling; Breast Cancer therapy; Genomic Basis; Professional/practitioner; BB

Potential Contributors and Temptative Titles Section I: The biology of the mammary gland: Jose Russo, Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA Title: Mammary gland development Gilbert H. Smith Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, 20892, Maryland Title: Mammary gland, stem cells and breast cancer Section II: The genetic background of breast cancer Barbara L. Weber, Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 514 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA Title: The genetic of breast cancer: application in clinical practice Ashok R. Venkitaraman, University of Cambridge, CR UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, U.K Title: Cancerogenesis associated with mutations in BRCA genes Section III: Epigenetic and molecular alterations in breast cancer Nancy E. Davidson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Room 409, Baltimore, MD 21231 Title: DNA methylation in breast cancer Antonio Giordano, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USA Title: Alterations of cell cycle regulatory genes in breast cancer David S. Salomon, Tumor Growth Factor Section, Mammary Biology & Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg 10, Rm. 5B39, Bethesda, Maryland 20892 Title: Role of the cripto (EGF-CFC) family in mammary gland development and neoplasia William J Gullick, Department of Biosciences, University of Kent at Canterbury, Canterbury, Kent CT2 7NJ Title: Type I growth factor receptors and their ligands in breast cancer: clinical significance and future prospects for treatment William J. Muller, Institute for Molecular Biology and Biotechnology, Department of Biology, McMaster University, Hamilton, Ontario, Canada L8S 4K1 Title: Transgenic mouse models of breast cancer as model to study oncogene mediated signal transduction Section IV: New tools for diagnosis and prognostic assessment in breast cancer Eric S. Lander, Whitehead Institute/MIT Center for Genome Research, One Kendall Square, Building 300, Cambridge, Massachusetts 02139, USA Title: Gene expression profiling in breast cancer: clinical applications Emanuel F. Petricoin III, Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Boulevard, MS 4E3, Manassas, VA 20110 Title: Proteomics in breast cancer Section V: Novel therapeutic approaches Erik P. Winer, Dana-Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA. Title: The endocrine therapy of breast cancer in the era of the aromatase inhibitors Nicola Normanno, Cell Biology and Preclinical Models Unit, INT-Fondazione Pascale, Naples, Italy Title: Signal transduction inhibitors for treatment and prevention of breast cancer Jose Baselga, Vall d'Hebron, University Hospital, Department of Medical Oncology, Pg Vall d'Hebron, 119-129, E-08035 Barcelona, Spain. Title: Monoclonal antibodies in breast cancer therapy: current status and future development Carlos L. Arteaga, Department of Cancer Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232 USA Title: TGFbeta antagonists: a novel approach fro treatment of breast cancer? Francesco Perrone, Clinical Trials Unit, INT-Fondazione Pascale, Naples, Italy Integration of target based agents in current protocols of breast cancer therapy

Más, otros libros, que pueden ser muy parecidos a este:

Último libro similar:
9781603279451 Breast Cancer in the Post-Genomic Era (Springer)


< para archivar...